Safety of second-line chemotherapy with non-conventional fotemustine schedule in recurrent high grade gliomas: a single institution experience

By Gaviani P.  

Journal of Neuro-Oncology, Vol. 113, Iss. 3, 2013-07 ,pp. : 527-529

Springer Publishing Company

Access to resources Recommend Favorite

Combined chemotherapy with temozolomide and fotemustine in recurrent glioblastoma patients

By Gaviani Paola  

Journal of Neuro-Oncology, Vol. 104, Iss. 2, 2011-09 ,pp. : 617-618

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme

By Maier-Hauff Klaus   Ulrich Frank   Nestler Dirk   Niehoff Hendrik   Wust Peter   Thiesen Burghard   Orawa Helmut   Budach Volker   Jordan Andreas  

Journal of Neuro-Oncology, Vol. 103, Iss. 2, 2011-06 ,pp. : 317-324

Springer Publishing Company

Access to resources Recommend Favorite

Fotemustine and recurrent glioblastoma: possible new opportunities for an old drug

By Addeo Raffaele  

Cancer Chemotherapy and Pharmacology, Vol. 64, Iss. 5, 2009-10 ,pp. : 863-866

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and safety of first-line erlotinib in elderly patients with advanced non-small cell lung cancer

By          

Oncology Reports, Vol. 28, Iss. 2, 2012-01 ,pp. : 721-727

Spandidos Publications

Access to resources Recommend Favorite